Concepedia

Cédric Menard

CM

Statistics

Publications

36

Citations

5.1K

H-Index

26

Active since

2003

Affiliations

Inserm(Current)

Université de Rennes

Centre Hospitalier Universitaire de Rennes

Assistance Publique – Hôpitaux de Paris

Établissement Français du Sang

Cédric Menard is an author at Inserm specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

2003–2024

36

Publications

36

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

François Ghiringhelli, Cédric Menard, Pierre E. Puig et al. · Cancer Immunology Immunotherapy · 2006 · 1.2K citations · Full text

, , +17

CD4<b>+</b>CD25<b>+</b> regulatory T cells inhibit natural killer cell functions in a transforming growth factor–β–dependent manner

François Ghiringhelli, Cédric Menard, Magali Terme et al. · The Journal of Experimental Medicine · 2005 · 919 citations · Full text

, , +17

A novel dendritic cell subset involved in tumor immunosurveillance

Nathalie Chaput, Cédric Menard, Lionel Apétoh et al. · Nature Medicine · 2006 · 397 citations

, , +14

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

Nicolas F. Delahaye, Sylvie Rusakiewicz, Isabelle Martins et al. · Nature Medicine · 2011 · 318 citations · Full text

, , +11

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects

Christophe Borg, Magali Terme, Cédric Menard et al. · Journal of Clinical Investigation · 2004 · 287 citations · Full text

, , +17

1–5 of 36